The Kay Mitral Valve Repair in Coronary Artery Disease Concomitant With Ischemic Mitral Regurgitation


1 Department of Cardiac Surgery, Atherosclerosis Prevention Research Center, Faculty of Medical Sciences, Mashhad University of Medical Sciences, Mashhad, I R Iran.

2 Faculty of Medical Sciences, Mashhad University of Medical Sciences, Mashhad, I R Iran.


Background: Ischemic mitral regurgitation is a major source of morbidity and mortality of myocardial infarction. Surgical intervention for significant ischemic mitral regurgitation at the time of coronary artery bypass grafting (CABG) is controversial and has always presented a great challenge. The purpose of this study was to describe the current surgical options for ischemic mitral incompetency and to discuss when mitral valve repair via the Kay method may be favored over mitral valve replacement. Methods: Twelve patients candidated for the Kay mitral valve repair plus CABG were recruited. The efficacy of mitral valve repair was echocardiographically recorded at follow-up. To validate the diagnosis of ischemic mitral regurgitation, we conducted a detailed chart review— which included all preoperative cardiac imaging tests at the first, sixth, and 12th postoperative months, as well as the operative records and pathology reports. Results: Twelve patients (5 male and 7 female) underwent CABG plus the Kay mitral valve repair. All the patients had significant mitral valve incompetency, which was resolved in all of them (P<0.05). There was no preoperative or postoperative mortality. No further postoperative mortality was reported at 1 year’s follow-up. The Kay technique for mitral valve repair had a desirable result insofar as 8 (72.7%) patients had only mild mitral regurgitation and 4 (33.3%) had mild-to-moderate mitral regurgitation. Conclusions: In the current era and in Iran, mitral valve repair—especially via the Kay method—has been proven to confer improved short and long-term survival, decreased valve-related morbidity, and enhanced left ventricular function. Future randomized prospective clinical trials are needed to compare this cost-effective surgical technique with its counterparts. (Iranian heart Journal 2018; 19(3): 6- 14)


  1. Dayan V, Soca G, Cura L, Mestres CA. Similar survival after mitral valve replacement or repair for ischemic mitral regurgitation: a meta-analysis. Ann Thorac Surg. 2014;97:758–765.
  2. Wang J, Gu C, Gao M, Yu W, Yu Y. Mitral valve replacement therapy causes higher 30-day postoperative mortality than mitral valvuloplasty in patients with severe ischemic mitral regurgitation: a meta-analysis of 12 studies. Int J Cardiol. 2015;185:304–307
  3. Lorusso R, Gelsomino S, Vizzardi E, D’Aloia A, De Cicco G, Lucà F, et al. Mitral valve repair or replacement for ischemic mitral regurgitation? the Italian study on the treatment of ischemic mitral regurgitation (ISTIMIR) J ThoracCardiovasc Surg. 2013;145:128–139
  4. Micovic S, Milacic P, Otasevic P, Tasic N, Boskovic S, Nezic D, et al. Comparison of valve annuloplasty and replacement for ischemic mitral valve incompetence. Heart Surg Forum. 2008;11:E340–E345
  5. Bonacchi M, Prifti E, Maiani M, Frati G, Nathan NS, Leacche M. Mitral valve surgery simultaneous to coronary revascularization in patients with end-stage ischemic-cardiomyopathy. Heart vessels. 2006;21:20–27.
  6. Roshanali F, Vedadian A, Shoar S, Sandoughdaran S, Naderan M, Mandegar MH. When to repair ischemic mitral valve regurgitation? an algorithmic approach. Eur Surg. 2013;45:98–105
  7. Kron IL, Hung J, Overbey JR, Bouchard D, Gelijns AC, Moskowitz AJ, et al. Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation. J ThoracCardiovasc Surg. 2015;149:752–761
  8. McGee EC, Gillinov AM, Blackstone EH, Rajeswaran J, Cohen G, Najam F, et al. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J ThoracCardiovasc Surg. 2004;128:916–924
  9. Russo A, Grigioni F, Avierinos JF, Freeman WK, Suri R, Michelena H, et al. Thromboembolic complications after surgical correction of mitral regurgitation incidence, predictors, and clinical implications. J Am CollCardiol. 2008;51:1203–1211
  10. Lamas GA, Mitchell GF, Flaker GC, Smith SC, Jr, Gersh BJ, Basta L, et al. Clinical significance of mitral regurgitation after acute myocardial infarction. Circulation. 1997;96:827–833
  11. . Lam BK, Gillinov AM, Blackstone EH, Rajeswaran J, Yuh B, Bhudia SK, et al. Importance of moderate ischemic mitral regurgitation. Ann Thorac Surg. 2005;79:462–470
  12. Carpentier AChauvaud SFabiani JNDeloche ARelland JLessana A, et al: Reconstructive Surgery of Mitral Valve Incompetence. Ten-YearAppraisal. J Thoracic Cardiovasc Surgery 1980;79:338-348
  13. Carpentier A: Cardiac Valve Surgery—the “French Correction”. J ThoracCardiovascSurg 86:323-337,1983.
  14. Aklog L, Fisoufi F, Flores KQ, Chen RH, Cohn LH, Natahan NS, et al :  Does Coronary Artery bypass grafting alone correct moderate Ischemic Mitral Regurgitaion? Circulation 2001; 104:1-68-1-75
  15. Al- Radi OO, Austin PC, TU JV, David TE, Yau TM. Mitral repair versus replacement for ischemic Mitral regurgitation .the annals of thoracic surgery . 2005;79(4) : 1260-7
  16. Benedetto U, Melina G, Roscitano A, Fiorani B, Capuano F, Sclafani G, et al. Does combined mitral valve surgery improve survival when compared to revascularization alone in patients with ischemic MR?A meta-analysis on 2479 patients. J Cardiovasc Med. 2009;10:109–114.
  17. Lee R, Li S, Rankin JS, O’Brien SM, Gammie JS, Peterson ED, et al. Society of Thoracic Surgeons Adult Cardiac Surgical Database. Fifteen-year outcome trends for valve surgery in North America. Ann Thorac Surg. 2011;91:677–684
  18. Fattouch K, Guccione F, Sampognaro R, Panzarella G, Corrado E, Navarra E, et al. POINT: Efficacy of adding mitral valve annuloplasty to CABG in patients with moderate ischemic MR: a randomized trial. J ThoracCardiovasc Surg. 2009;138:278–285
  19. Chan KM, Punjabi PP, Flather M, Wage R, Symmonds K, Roussin I, et al. RIME Investigators. Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial. Circulation. 2012;126:2502–2510
  20. Michler RE, Rouleau JL, Al-Khalidi HR, Bonow RO, Pellikka PA, Pohost GM, et al. STICH Trial Investigators. Insights the STICH trial: change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction. J ThoracCardiovasc Surg. 2013;146:1139–145
  21. Beeri R, Yosefy C, Guerrero L, Abedat S, Handschumacher MD, Stroud RE, et al. Early repair of moderate ischemic MR reverses LV remodeling: a functional and molecular study. Circulation. 2007;116 I-288-I-293
  22. McGee EC1, Gillinov AMBlackstone EHRajeswaran JCohen GNajam F, et al :Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J ThoracCardiovasc Surg. 2004;128:916–924
  23. Kay JHTsuji HKRedington JVMendez AM The surgical treatment of mitral insufficiency associated with torn chordae tendineae. Vasc Surg. 1968 Dec;2(4):189-93.
  24.  Jerome Harold Kay and William S. Egerton. The Repair of Mitral Insufficiency Associated with Ruptured Chordae Tendineae. Ann Surg. 1963 Mar; 157(3): 351360. PMCID: PMC1466378.
  25. Revuelta Soba JM. [Mitral valve reconstruction: classic concepts for new indications].An R Acad Nac Med (Madr). 2004;121(3):475-84; discussion 484-6.
  26. Abicht TOAndrei ACKruse JMcDonald ELi ZMcCarthy PM J Thorac Cardiovasc Surg. A simple approach to mitral valve repair: posterior leaflet height adjustment using a partial fold of the free edge. 2014 Dec;148(6):2780-6.
  27. Hetzer R1Delmo Walter EM. No ring at all in mitral valve repair: indications, techniques and long-term outcome.Eur J Cardiothorac Surg. 2014 Feb; 45(2):341-51.
  28. Hetzer RSolowjowa NSiniawski HDelmo Walter EM. Posterior annulus shortening increases leaflet coaptation in ischemic mitral incompetence: a new and valid technique. Ann Cardiothorac Surg. 2015 May;4(3):238-48.
  29. Jensen H. Surgical treatment of functional ischemic mitral regurgitation.Dan Med J. 2015 Mar; 62(3). Pii: B4993.
  30. Nappi FSpadaccio CChello MMihos CG. Papillary muscle approximation in mitral valve repair for secondary MR.J Thorac Dis. 2017 Jun;9(Suppl 7):S635-S639.
  31. Nappi FSpadaccio CNenna ALusini MFraldi MAcar CChello M. Is subvalvular repair worthwhile in severe ischemic mitral regurgitation? Subanalysis of the Papillary Muscle Approximation trial.J Thorac Cardiovasc Surg. 2017 Feb;153(2):286-295.e2.
  32. Fraldi MSpadaccio CMihos CGNappi F. Analysing the reasons of failure of surgical mitral repair approaches-do we need to better think in biomechanics?J Thorac Dis. 2017 Jun;9(Suppl 7):S661-S664.
  33. Tibayan FA1Rodriguez FLanger FLiang DDaughters GTIngels NBMiller DC Mitral suture annuloplasty corrects both annular and subvalvular geometry in acute ischemic mitral regurgitation.J Heart Valve Dis. 2004 May;13(3):414-20.
  34. Nappi FSpadaccio CChello MMihos CG. Papillary muscle approximation in mitral valve repair for secondary MR.J Thorac Dis. 2017 Jun;9(Suppl 7):S635-S639.